Tokyo, Oct. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063229) titled 'An Exploratory Study on the Cytotoxic Activity of Immune Cells Using Existing Samples' on Oct. 13.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Meiji Co., Ltd.
Condition:
Condition - Healthy Adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To assess the cytotoxic activity of circulating immune cells using existing samples.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 35
years-old
Gender - Male and Female
Key inclusion criteria - Subjects of the other study (UMIN000056115)
Key exclusion criteria - 1. Subjects who expressed their intention to withdraw from the study after the disclosure of information regarding its conduct.
2. Subjects from whom no blood sample was obtained in the other study (UMIN000056115).
Target Size - 59
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 09 Month 14 Day
Date of IRB - 2026 Year 09 Month 17 Day
Anticipated trial start date - 2026 Year 10 Month 14 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072371
Disclaimer: Curated by HT Syndication.
